2018
DOI: 10.1089/ham.2017.0126
|View full text |Cite
|
Sign up to set email alerts
|

Exploration of Acute Phase Proteins and Inflammatory Cytokines in Early Stage Diagnosis of Acute Mountain Sickness

Abstract: Acute phase proteins and inflammatory cytokines (IL-1β, IL-6, and TNF-α) show significant changes between the AMS group and the non-AMS group. Combination of inflammatory cytokines or acute phase proteins improves the specificity for diagnosis of AMS. This might provide objective indexes for scanning and screening individuals susceptible to AMS in the early stage of rapid ascending.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
37
1

Year Published

2019
2019
2023
2023

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 38 publications
(40 citation statements)
references
References 43 publications
2
37
1
Order By: Relevance
“…Here, IL-1β mRNA expression was increased and this was associated with an increased LLS. Thus, one might emphasize that alteration in serum cytokine concentrations under hypoxia might be associated with clinical symptoms of AMS: this is in accordance with previous studies showing that IL-1β, IL-6, and TNF-α were increased in AMS patients, or that an inhibition of anti-inflammatory IL-10 was associated with AMS in a genome wide study [31,37,38]. In contrast, other studies did not find an association between circulating cytokines like IL-3, IL-6, or IL-10, exercise and AMS [38][39][40].…”
Section: Discussionsupporting
confidence: 89%
See 1 more Smart Citation
“…Here, IL-1β mRNA expression was increased and this was associated with an increased LLS. Thus, one might emphasize that alteration in serum cytokine concentrations under hypoxia might be associated with clinical symptoms of AMS: this is in accordance with previous studies showing that IL-1β, IL-6, and TNF-α were increased in AMS patients, or that an inhibition of anti-inflammatory IL-10 was associated with AMS in a genome wide study [31,37,38]. In contrast, other studies did not find an association between circulating cytokines like IL-3, IL-6, or IL-10, exercise and AMS [38][39][40].…”
Section: Discussionsupporting
confidence: 89%
“…It is known that both exercise and hypoxia can alter mRNA expression and protein release of pro-and anti-inflammatory cytokines, like interleukin-1β (IL-1β), IL-6, or IL-10, activate lymphocytes, alter chemokine receptors, or induce further signaling pathways of the hypoxic inflammatory response [27][28][29]. Especially, in high altitude cerebral edema (HACE) proinflammatory cytokines like IL-1β, IL-6, or vascular endothelial growth factor A (VEGF-A) are believed to play an important role [30,31]. Apart from pro-and anti-inflammatory cytokines, the role of chemokines is of particular importance, as chemokine expression and its ligands are crucial for immune cell migration, e.g., in neuroinflammatory processes, and could therefore also be of interest with respect to hypobaric hypoxia-induced AMS and high altitude cerebral edema (HACE) [32][33][34].…”
Section: Introductionmentioning
confidence: 99%
“…interleukin 1β (IL-1β), and interleukin 6 (IL-6) (Bouchama et al 1993) and lower concentrations of interleukin 10 (IL-10) (Welc et al 2013). Of note, individuals that develop acute mountain sickness (AMS), which is a common illness during travel to high altitude (Burns et al 2018), also exhibit elevated circulating concentrations of inflammatory cytokines (TNF-α, IL-1β, and IL-6) (Wang et al 2018) and lower levels of anti-inflammatory cytokines (IL-10 and IL-1Ra) (Liu et al 2017). In contrast, higher levels of anti-inflammatory cytokines have been shown to afford protection against AMS (Julian et al 2011).…”
Section: Introductionmentioning
confidence: 99%
“…AMS is a predominant neurological disorder, and it is controversial whether minor impairments of gas exchange contribute to this disease (Cremona et al, 2002;Senn et al, 2006;Dehnert et al, 2010;Berger et al, 2017;Lipman et al, 2017). The significance of inflammation in AMS is in general unclear, as previous studies found either no ( Johnson et al, 1988;Kleger et al, 1996;Swenson et al, 1997;Julian et al, 2011) or only a moderate (Hartmann et al, 2000;Boos et al, 2016;Lundeberg et al, 2018;Wang et al, 2018) increase (of about 1.5-to 3.5-fold) in proinflammatory cytokines in subjects with AMS. Even if some mild inflammation is part of the pathophysiology of AMS, it does not induce organ damage and its significance in the disease's pathogenesis is far smaller than in COVID-19.…”
Section: Role Of Inflammationmentioning
confidence: 99%